Association of ABCC2 and CDDP-resistance in two sublines resistant to CDDP derived from a human nasopharyngeal carcinoma cell line

Journal of Oncology

Volumn , Issue , 2010, Pages

  Yao, Kai Tai ^a   Xie, Si Ming ^a,b   Fang, Wei Yi ^a   Liu, Teng Fei ^a   Zhong, Xue Yun ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER C1; ABC TRANSPORTER C2; BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; FLUOROURACIL; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG; VALSPODAR;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; IC 50; MULTIDRUG RESISTANCE; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION;

EID: 77954582425     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/915046     Document Type: Article

References (31)

1. Wu J., Xiao X., Zhao P., Minicircle-IFN induces antiproliferative and antitumoral effects in human nasopharyngeal carcinoma Clinical Cancer Research 2006 12 15 4702 4713
2. Her C., Nasopharyngeal cancer and the southeast Asian patient American Family Physician 2001 63 9 1776 1785
3. Ahmad A., Stefani S., Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients Journal of Surgical Oncology 1986 33 3 194 197
4. Lee A. W. M., Lau W. H., Tung S. Y., Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group Journal of Clinical Oncology 2005 23 28 6966 6975
5. Ngan R. K. C., Yiu H. H. Y., Lau W. H., Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study Annals of Oncology 2002 13 8 1252 1258
6. Dimery I. W., Hong W. K., Overview of combined modality therapies for head and neck cancer Journal of the National Cancer Institute 1993 85 2 95 111
7. Szakcs G., Paterson J. K., Ludwig J. A., Booth-Genthe C., Gottesman M. M., Targeting multidrug resistance in cancer Nature Reviews Drug Discovery 2006 5 3 219 234
8. Dean M., Rzhetsky A., Allikmets R., The human ATP-binding cassette (ABC) transporter superfamily Genome Research 2001 11 7 1156 1166 (Pubitemid 32677289)
9. Taniguchi K., Wada M., Kohno K., A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation Cancer Research 1996 56 18 4124 4129
10. Xie S. M., Fang W. Y., Liu Z., Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin Journal of Translational Medicine 2008 6, article 55
11. Thomas H., Coley H. M., Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein Cancer Control 2003 10 2 159 165
12. Zhou N.-N., Zhu X.-F., Zhou J.-M., 2-methoxyestradiol induces cell cycle arrest and apoptosis of nasopharyngeal carcinoma cells Acta Pharmacologica Sinica 2004 25 11 1515 1520
13. Wu X., Fan W., Xu S., Zhou Y., Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells Clinical Cancer Research 2003 9 16 5874 5879
14. Ishida Y., Ohtsu T., Hamada H., Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16 Japanese Journal of Cancer Research 1989 80 10 1006 1013 (Pubitemid 20028818)
15. Zheng X., Shen G., Yang X., Liu W., Most C6 cells are cancer stem cells: evidence from clonal and population analyses Cancer Research 2007 67 8 3691 3697
16. Seyhan A. A., Vlassov A. V., Ilves H., Complete, gene-specific siRNA libraries: production and expression in mammalian cells RNA 2005 11 5 837 846
17. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method Methods 2001 25 4 402 408
18. Smith J. L., Rangaraj K., Simpson R., Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR Journal of Lipid Research 2004 45 4 686 696
19. Krag D. N., Kusminsky R., Manna E., The detection of isolated tumor cells in bone marrow comparing bright-field immunocytochemistry and multicolor immunofluorescence Annals of Surgical Oncology 2005 12 9 753 760
20. Gao L., Lu C., Xu C., Tao Y., Cong B., Ni X., Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts Endocrinology 2008 149 6 2866 2876
21. Lanjwani S. N., Zhu R., Khuhawar M. Y., Ding Z., High performance liquid chromatographic determination of platinum in blood and urine samples of cancer patients after administration of cisplatin drug using solvent extraction and N, N′ -bis(salicylidene)-1,2-propanediamine as complexation reagent Journal of Pharmaceutical and Biomedical Analysis 2006 40 4 833 839
22. Surowiak P., Materna V., Kaplenko I., Nuclear membraneous localization of ABCC2(MRP2,cMOAT) in ovarian carcinoma cells can correlate with resistance to platinum-containing drugs and clinical outcome Proceedings of the American Association for Cancer Research 2006 47 597 603
23. Keppler D., Leier I., Jedlitschky G., Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2 Biological Chemistry 1997 378 8 787 791
24. Evers R., Kool M., van Deemter L., Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA The Journal of Clinical Investigation 1998 101 1310 1319
25. Borst P., Kool M., Evers R., Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? Seminars in Cancer Biology 1997 8 3 205 213
26. Kool M., de Haas M., Scheffer G. L., Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines Cancer Research 1997 57 16 3537 3547
27. Guminski A. D., Balleine R. L., Chiew Y.-E., MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma Gynecologic Oncology 2006 100 2 239 246
28. Materna V., Stege A., Surowiak P., Priebsch A., Lage H., RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells Biochemical and Biophysical Research Communications 2006 348 1 153 157 (Pubitemid 44163494)
29. Lopez-Flores A., Jurado R., Garcia-Lopez P., A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples Journal of Pharmacological and Toxicological Methods 2005 52 3 366 372
30. Liscovitch M., Lavie Y., Cancer multidrug resistance: a review of recent drug discovery research IDrugs 2002 5 4 349 355
31. Bhme M., Bchler M., Mller M., Keppler D., Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane FEBS Letters 1993 333 1-2 193 196